Table of Content - Blood And Blood Components Market

Blood is a specialized bodily fluid that circulates through the entire body with the help of a network of blood vessels such as arteries, veins, and capillaries. Blood is made up of four major components, which include red blood cells, white blood cells, plasma, and platelets. Red blood cells, also known as erythrocytes or RBC account for the major portion of blood cells. RBC have a specialized red colored pigment called hemoglobin, which is responsible for carrying oxygen rich blood from the lungs to the rest of the body and deoxygenated blood from the body to the lungs. The average life cycle of RBC is 120 days after which they are removed by the spleen. White blood cells, also known as leukocytes are responsible for making the immune system of the body and help fight against microbial infections. Plasma is the liquid component of blood and is a mixture of water, protein, sugar, salts, and fat. Platelets, also known as thrombocytes help in clotting of blood at the site of tissue injury. Whole blood consists of 45% blood cells and 55% plasma.

According to the American Society of Hematology, blood makes up around 7 to 8% of human body weight. Blood and blood components are used for blood transfusion in case of blood loss during a traumatic injury, hemorrhage to maintain blood volume during cancer treatment, and to treat bleeding disorders.

Market Dynamics

The increasing incidence of bleeding disorders and chronic diseases, rising research and development activities for the development of novel technology for the treatment of bleeding disorders, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global blood and blood components market over the forecast period.

For instance, according to the statistics provided by the World Federation of Hemophilia (WFH) in 2018, over 400,000 people suffered from hemophilia of which around 173,000 people were diagnosed with hemophilia A or B in 2017, across the globe.

Key features of the study

This report provides in-depth analysis of the global blood and blood components market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood and blood components market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton, Dickinson & Co., Kidde-Fenwal Inc., Bio-Rad Laboratories, Inc., Cerus Corporation, Immucor, Beckman Coulter, Inc., bioMérieux SA, Octapharma AG, Abbott, CSL Behring LLC, MacoPharma, Shanghai RAAS, China Biologic Products Holdings, Inc., Takeda Pharmaceutical Company Limited, Grifols S.A., Bharat Serums and Vaccines Ltd., and Terumo BCT Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood and blood components market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood and blood components market

Market Segmentation

By Product Type (Revenue, USD Bn, 2021-2033)
- Whole Blood
- Blood Components
- Red Blood Cells
- White Blood Cells
- Platelet
- Plasma
By Application (Revenue, USD Bn, 2021-2033)
- Anemia
- Trauma and Surgery
- Cancer Treatment
- Bleeding Disorders
- Others (Others include rare blood diseases)
By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Ambulatory Surgical Centers
- Blood and Blood Component Bank
- Others
By Region (Revenue, USD Bn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Key Players
- Becton, Dickinson & Co.
- Kidde-Fenwal Inc.
- Bio-Rad Laboratories, Inc.
- Cerus Corporation
- Immucor
- Beckman Coulter, Inc.
- bioMerieux SA
- Octapharma AG
- Abbott
- CSL Behring LLC
- MacoPharma
- Shanghai RAAS
- China Biologic Products Holdings, Inc.
- Takeda Pharmaceutical Company Limited
- Grifols S.A.
- Bharat Serums and Vaccines Ltd.
- Terumo BCT Inc.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Product Type
  - Market Snapshot, By Application
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter’s Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
Global Blood and Blood Components Market, By Product Type, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Whole Blood
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Blood Components
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    - Red Blood Cells
    - White Blood Cells
    - Platelet
    - Plasma
Global Blood and Blood Components Market, By Application, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Anemia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Trauma and Surgery
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Cancer Treatment
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Bleeding Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Others (Others include rare blood diseases)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
Global Blood and Blood Components Market, By End User, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Hospital
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Ambulatory Surgical Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Blood and Blood Component Bank
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
Global Blood and Blood Components Market, By Region, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
  - Becton, Dickinson & Co.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Kidde-Fenwal Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Bio-Rad Laboratories, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Cerus Corporation
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Immucor
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Beckman Coulter, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - bioMerieux SA
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Octapharma AG
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Abbott, CSL Behring LLC
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - MacoPharma
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Shanghai RAAS
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - China Biologic Products Holdings, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Grifols S.A.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Bharat Serums and Vaccines Ltd.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Terumo BCT Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE